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Abstract
MitoNEET, a mitochondrial membrane protein with an unsymmetrical Fe-S cluster
coordination, was compared to similar proteins within the Rieske and Ferredoxin families. Point
mutations were introduced via site-directed mutagenesis to induce stability, greater retention of
the cluster, and to uncover structural limitations of the protein. Mutations were made within the
cluster coordination and within the hydrophobic core of the protein. Some of the cluster
mutations displayed a natural affinity for nickel during immobilized metal-ion affinity
chromatography. It is possible that these mutations aid in the formation of a chelate when
exposed to nickel. Spectroscopic monitoring of changes in cluster stability under low pH
conditions was used to compare cluster retention across mutations. Some of the cluster mutants
displayed a significant increase in stability versus wild type and other mutated forms of the
protein. The hydrophobic mutations were found to push structural limitations of the protein by
disrupting the hydrophobic core, even in the presence of the stabilizing cluster mutations. These
mutation results would benefit from further structural research.

Introduction
Iron-sulfur clusters (Fe-S) are a common post-translational addition made to certain proteins,
providing a structural element necessary to their function inside the cell. The mechanism of Fe-S
formation is yet unknown, however proteins containing a Fe-S have been shown to play a part in
intracellular signaling, redox potential, and electron transport.1,2 There are two common [2Fe-2S]
clusters found within known proteins. First is the Rieske center, which contains a [2Fe-2S]
cluster coordinated by two histidine and two cysteine residues. These are commonly expressed in
proteins like cytochrome bc1 complex (Figure 1A).1 The second Fe-S is common to the
ferredoxin group. Ferredoxin contains a four-cysteine residue coordination geometry around its
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[2Fe-2S] cluster (Figure 1B). Apparent
in Figure 1, both [2Fe-2S] cluster
coordinations are symmetrical, and are
evolutionarily conserved to stabilize and
retain the cluster.
Within the last 10 years a new cluster
coordination was revealed within
mitoNEET, an outer mitochondrial
membrane protein. This homodimeric
protein contains the sequence asparagineglutamic acid-glutamic acid-threonine (NE-E-T), from which its name is derived.3

Figure 1. A. Cytochrome bc1 complex (left), revealing the two
histidine, two cysteine [2Fe-2S] Rieske cluster coordination. B.
Ferredoxin (left), demonstrating the four cysteine [2Fe-2S]
cluster coordination (right).1

MitoNEET displays a three cysteine and one histidine cluster coordination geometry, which
contradicts symmetrical characteristic of both Reiske and ferredoxin [2Fe-2S] clusters (Figure
2). MitoNEET’s cluster coordination was named the CCCH-type [2Fe-2S] binding motif. When
reduced, the cluster contains an Fe2+ ([Ar]3d6), Fe3+ (Ar]3d5), and 2 S ([Ne] 3s23p4) molecules.1
Whereas when oxidized, it contains 2 Fe3+ (Ar]3d5) and 2 S ([Ne] 3s23p4) molecules.1 Multiple
proteins were found to contain this motif including: IscR, Miner1 and Grx3/4-Fra2, all of which
deal with redox homeostasis of the cell.4 The redox potential of mitoNEET was found to be +35
mV at pH 7.5, differing from the Reiske (+300 mV) and Ferredoxin (-300 mV) center.2 Different
studies were done with these proteins by mutating their cluster coordination residues to mimic
more stable coordinations under different conditions, such as pH, temperature, and
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concentration.5,6 These studies have lead to
increased productivity and more efficient
functionality within the cell.
The structure of mitoNEET reveales a
buried interface.7,7 A strand swap β-sheet
hydrophobic core is at the center of each
monomer which is flanked on either side by a
loop cradle containing the [2Fe-2S] cluster. The
residue of most importance in recent studies
was the easily deprotonated H87 residue.8 The
H87 residue was mutated to a cysteine at that
Figure 2. Wild type dimer mitoNEET demonstrating
the unique CCCH-Type [2Fe-2S] binding motif.
Each monomer is displayed (green/silver) and the
[2Fe-2S] clusters (yellow/orange). The cluster
coordination includes the following four residues at
their designated positions: C72, C74, C83, H87.2

position, creating a more distinguished Reiske
center9. This mutation increased stability,
especially when in the presence of Pioglitazone,

a drug used in the treatment of type 2 diabetes.10,11 Previous stability research done on the H87C
mutation made it a candidate for a source of double mutations. Although we are aware of
location and cluster stability habits of mitoNEET, its function and transfer behaviors are still
unknown. Stability of ferredoxin and Rieske [2Fe-2S] give a good indication of how
mitoNEET’s cluster would behave if substituted with a more stable cluster coordination.12
Although it was suggested that this unique unstable cluster is intrinsic to the protein’s metabolic
role.
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The hydrophobic core is an important avenue of study for this protein. Disruption of the
hydrophobic core can lead to an inability to retain the cluster. The hydrophobic core can also be
utilized to obtain data on retention of the cluster and determine its structural limitations.
MitoNEET binds with pioglitazone.. Pioglitazone utilizes the protein’s 7 residue binding
pocket to create a protein-drug complex, stabilizing mitoNEET’s [2Fe-2S] cluster.13,14
MitoNEET was suggested to play a role in activation of glutamate dehydrogenase, an insulin
regulator, by allowing a cysteine at the 74 position of mitoNEET to form a disulfide bond with a
cysteine at the 319 position of the regulator.15,16 This research makes mitoNEET a topic for
discussion due to the high number of people affected by type 2 diabetes.

Experimental Details
Site Directed Mutagenesis
WT MitoNEET sequence was analyzed utilizing Chromas (Technelysium, Australia). This
sequence was used with Aligent’s primer design webtool to produce PCR primers for site
directed mutagenesis (SDM). Primers were made to introduce point mutations in the Fe-S cluster
cradle, in addition to residues that were thought to play a role in stabilizing the hydrophobic core.
Residues altered by SDM are summarized in table 1. Since there is a significant amount of
previous data on stability and effects of the H87C mutant, double mutants were made with H87C
and various cluster cradle residues.17 (Table 1) Polymerase chain reaction (PCR) reactions were
carried out with the following cycle condition: 30 seconds 95°, 14 cycles of 30 seconds at 95°,
1 minute at 55 °, 4 minutes at 68°. The thermocycler was held at 4° until the the sample was
ready to be removed. A QuickChange II XL Site-Directed Mutagenesis Kit (Aligent
Technologies, Santa Clara, CA) was used. A pET3a expression vector with a T7-inducible
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promoter, and ampicillin resistance gene was transformed into XL10-Gold ultracompetent cells,
and the transformed cells were plated on LB/Ampicillin plates.18
Table 1. This table displays mutated residues, position in the sequence, and location within mitoNEET.
Also present is a overview of cluster coordination present following the mutation.

Original Residue
Histidine
Phenylalanine
Cysteine
Cysteine
Cysteine
Histidine
Cysteine
Histidine
Cysteine
Histidine
Cysteine
Histidine
Glycine
Histidine
Tryptophan

New Residue
Cysteine
Alanine
Histidine
Histidine
Histidine
Cysteine
Histidine
Cysteine
Histidine
Cysteine
Histidine
Cysteine
Alanine
Cysteine
Phenylalanine

Position
87
60
83
74
72
87
83
87
74
87
72
87
66
87
75

New Cluster
Coordination
Ferredoxin Center
CCCH-Type
Rieske
Rieske
Rieske
CCCH-Type
(relocation of H)
CCCH-Type
(relocation of H)
CCCH-Type
(relocation of H)
Rieske

Location of
Mutation
Cluster Cradle

Name
H87C

Hydrophobic Core

F60A

Cluster Cradle
Cluster Cradle
Cluster Cradle
Cluster Cradle
Cluster Cradle
Cluster Cradle
Cluster Cradle
Cluster Cradle
Cluster Cradle
Cluster Cradle

C83H
C74H
C72H
H87C
C83H
H87C
C74H
H87C
C72H
H87C
G66A
H87C
W75F

Hydrophobic Core

Rieske

Cluster Cradle
Hydrophobic Core

Miniprep and Transformation
A Plasmid Miniprep II E.Z.N.A. kit was used to conduct the miniprep (Genex Technologies,
OR). Plasmid vectors were transformed into ultracompetent XL10-Gold E. coli cells (Lucigen),
where induced expression of mutation-containing vector produces high mitoNEET levels within
the cells. 19 After plasmid miniprep, a bacterial transformation in C43 competent cells with
expression media was done.20,21 An ampicillin resistance gene allows specific retention of cells
that have incorporated the plasmid. By plating cells onto an ampicillin plate, all bacterial cells
that do not have the ampicillin gene resistance will die, leaving cells viable for induced protein
expression.

Expression and Isolation of MitoNEET
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2xYT media supplemented with ampicillin (100 /

was utilized to induce protein

expression. A small 25 mL overnight culture was grown to stationary phase at 37° and 260 rpm
using a 250 mL fernbach flask. This culture was used to inoculate a larger culture (500 mL) the
following morning. Optical density (OD600) was taken every 20 minutes using a sample of 2xYT
taken prior to inoculation as a negative control (Table 2).
Table 2. Provides the actions taken at the corresponding optical density values.

OD600
~0.200
~0.700
~0.800

Action
Add 1 Iron (III) Chloride Solution
Drop temperature to 29°
Add 0.50 mM IPTG

Large cultures were induced for 10 hours with 0.5 mM Isopropyl -D-1-thiogalactopyranoside
(IPTG) after reducing the temperature to 18 °. Cells were pelleted by centrifugation at 14,000
times gravity for 15 minutes. These pellets were stored at -20°.
Before lysis, pellets were allowed to thaw at room temperature for 30 min and resuspended in
25 mL of wash buffer (50mM Tris-HCL pH 8.5, 200 mM NaCl, 20mM Imidazole). This was
vortexed into solution to create a cell paste. At this point the protease inhibitors
phenylmethanesulfonylfluoride (PMSF), leupeptin, and benzamidine were added. Cell paste was
lysed using a French pressure cell. Three passes were utilized to ensure complete lysis. Crude
lysate was centrifuged at 14000 times gravity for 12 minutes and supernatant was retained. The
lysed supernatant was further purified utilizing a 0.22 μm syringe filter before injecting it into an
ÄKTA fast protein liquid chromatography (FPLC) system for purification.
Immobilized metal ion affinity chromatography (IMAC) was used to isolate mitoNEET from
unwanted lysate materials. The IMAC uses interactions between immobilized transition metals,
in this case Ni 2+, and specific amino acid residues, such as histidine. Since the protein contains a
6-Histidine tag, it coordinates Ni on the column resin and sticks to the His-Trap while everything
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else is washed through the column into waste. MitoNEET was collected in fractions by a
gradient elution with buffer B (50mM Tris
Tris-HCL pH 8.5, 200 mM NaCl, 400mM/600mM
/600mM
Imidazole).
). Each of the fractions were assessed for protein content via A280. A Bradford standard
curve was established to more accurately determine concentration (Table
Table 3, Figure 3 and Figure
4). 22

Table 3. (Left) Values utilized in producing
ucing the mitoNEET Bradford curv
curve.
[MitoNEET]

Absorbance
0.002

1.2

0.010 mM

0.09

1

0.025 mM

0.169

0.050 mM

0.28

0.075 mM

0.365

0.100 mM

0.456

Absorbance

0.005 mM

MitoNEET Bradford Standard Curve
y = 0.0961x - 0.1077
R² = 0.9959

0.8
0.6
0.4

0.200 mM

0.59

0.260 mM

0.651

0.300 mM

0.738

0

0.400 mM

0.828

-0.2
0.2

0.519 mM

0.992

0.2
0

2

4

6

8

10

12

[MitoNEET] (mM)

Figure 3. (Right) The Bradford curve produced by Table 3. This Bradford curve was used
sed to assess the
mitoNEET content in fractiosn lacking apparent color.

Figure 4. The signature Bradford color differences in the presence of protein in a fraction.
Concentration of mitoNEET from left to right: 0.40 mM, 0.30 mM, 0.20 mM, 0.10 mM, 0.075 mM,
0.050 mM, 0.025 mM, 0.010 mM, 0.005 mM.

Fractions determined to contain mitoNEET were pooled and dialyzed in 1L of dialysis buffer
(50 mM Tris-HCl
HCl pH 8.5, 300 mM NaCl) utilizing 10 kDa SnakeSkin dialysis tubing. The
sample dialyzed for an hour prior to the addition of thrombin to cleave the 6 histidine
istidine tag.
Dialysis was allowed to complete overnight (<18 hours). A second FPLC was used to isolate
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mitoNEET from the cleaved tag. Alternatively, size exclusion chromatography (SEC) was later
used in lieu of a second HisTrap. The 6-His tag would be separated out in both procedures,
making the second HisTrap useless. This sample was dialyzed to remove the imidazole.
Final step of purification was to use SEC as a polishing method, however a sample size of <
2 mL was necessary. All mitoNEET samples were concentrated prior to being injected into the
column. An Amicon stir cell with a 10 kDa filter was used to concentrate mitoNEET.
Throughout isolation of mitoNEET, a 10 kDa filter was used because the cluster-containing
dimer is approximately 22 kDa. It was optimal to filter for the dimer rather than the 11 kDa
monomer. After concentration, it was injected into the size exclusion column and run through
with SEC buffer (50 mM Tris pH 8.5, 150 NaCl). Size exclusion columns work by separating out
different size compounds within a solution. Larger compounds flow over with little interaction
with the resin and come through the column quickly. Monomer and dimer mitoNEET come off
at specific volumes that correspond to their size. This way it is easy to select which form one
would like to collect and concentrate. This column removes almost all imidazole present, which
is helpful for nuclear magnetic resonance (NMR) experiments. Since this is a 100 mL column, it
will severely dilute the sample. It is necessary to concentrate samples prior to using them in any
type of assay or further experiment.

pH-Dependent Cluster Stability
Three different citric acid buffers were made at a pH of 4, 5, and 6 at different concentrations.
A concentration of 25 

of mitoNEET was added to 50 mM, 75 mM, or 100 mM citric acid

buffer in a final volume of 500 μL. Absorbance at 457 nm was collected in 10 minute intervals.
At 457 nm is where the Fe-S cluster absorbs maximally, therefore monitoring cluster loss over
time. Two mitoNEET samples were used, H87C G66A and wild type (WT). H87C G66A mutant
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acted as a single mutant because the G66A mutation had no effect on the cluster or hydrophobic
core. The goal of this experiment was to test pH stability of WT and H87C mutant mitoNEET. If
done correctly, the H87C mutant is significantly more stable than WT.

H87C Mutant Natural Nickel Affinity
H87C mutants exhibited a natural nickel affinity therefore making the protein difficult to
elute off the column and producing lower yields. Imidazole was used to release the 6-histidine
tag from the column. If a higher imidazole concentration were employed in the elution buffer, it
would override mitoNEET’s natural affinity for Ni. Before increasing imidazole concentration
on an entire sample, one sample was split into two sections to support homogeneity within
expression procedures leading up to the HisTrap. The first section was eluted using 400 mM
imidazole buffer and the second using an increased 600 mM imidazole buffer. Absorbance at
457 nm and 280 nm were both measured following fraction collection.

MitoNEET X-Ray Crystallography
H87C, WT, and H87C C83H samples were concentrated between 12 mg/mL and 16
mg/mL using a centrifuge10 kDa filter.23,24 Sitting drop method was used with the buffers found
in Appendix B. They sat for 3-5 days and wells were checked for precipitation and crystals.

Gel Electrophoresis
Sodium-dodecyl sulfate (SDS) was used in conjunction with a 15% polyacrylamide gel
electrophoresis to determine purity of each protein sample. SDS is a detergent that denatures
protein, allowing it to separate based on molecular weight. A sample was taken during each stage
of synthesis and purification for each mutant. Samples were denatured and dyed with an equal
volume of 2X SDS 10% 2-mercaptoethanol (BME) solution. This solution was added to the
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density so it would remain in the well. They were heated to 95°, agitated and spun down. 1X
TAE (tris base, acetic acid, and EDTA) buffer was added to the gel apparatus to keep the gel
wet, aid in electrical current, and cooling to avoid melting. Samples and ladder were placed in
the gel and run for 30 minutes at 200 mV. Coomaisse Brilliant Blue was used as the stain and
water as destain to see protein bands on the gel.

Results & Discussion
Expression and Isolation of MitoNEET
Concentration of each protein was recorded along with amount and cluster presence via
absorbance spectroscopy at 280 nm and 457 nm respectively (Table 4). Protein aggregated
within the stir cell once it was at approximately 0.800 mM, therefore values were monitored and
kept below this concentration. The only mutants that did not retain their cluster were W75F and
C83H. W75F was a mutation found within the hydrophobic core, whereas the C83H was part of
the cluster coordination. It is possible that the W75F mutation successfully disrupted the
hydrophobic core, which may have altered the structure and released the cluster. All that can be
drawn from the data thus far is that the H87C W75F mutant did not retain its cluster. W75F was
explored further through size exclusion chromatography to determine its final configuration
(Figure 5C). The C83H mutation relocates a histidine residue to the outermost portion of the
cluster, leaving it to interact with the solvent. The histidine could have deprotonated and affected
the stability of the cluster. The H87C and C83H double mutant is stable however the H87C could
be over-compensating for the C83H.
Table 4. Amount of each mutant successfully made and their [Fe-S] cluster presence via the
457 nm absorbance reading.

Mutation
H87C

Concentration Amount (mL)
0.350 mM
1.5 mL

Absorbance (457 nm)
0.003
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W75F
H87C
G66A
F60A
H87C
C83H
C74H
C72H
H87C
C83H
H87C
C74H
H87C
C72H
WT

0.754 mM
0.554 mM
0.726 mM
0.334 mM
0.537 mM
0.621 mM

1.8 mL
2.3 mL
3.8 mL
1.7 mL
1.2 mL
2.0 mL

0.587
0.511
0.609
0.009
0.459
0.501

0.634 mM

2. 4 mL

0.566

0.523 mM

1.5 mL

0.492

0.544 mM
0.759 mM

1.6 mL
4.2 mL

0.527
0.697

Size exclusion chromatography provided data on the molecular weight of each mitoNEET
sample and its purity (Figure 5). This data was utilized to determine if mutants produced
monomer or dimer configurations and the effect this had on the presence of the Fe-S cluster.
Results for the majority of mutants were dimer and cluster-containing. The only difference was
seen with the W75F mutant, which presented itself solely in the monomer configuration. WT and
H87C mitoNEET are displayed for comparison of the cluster-containing dimer configuration
elution at 115 mL (Figure 5B). One can see minor absorbance peaks early on in the
chromatogram, but this is aggregated product coming off the column. The H87C W75F
displayed none of the characteristic red color throughout purification, verifying the absence of
the Fe-S cluster. This protein eluted from the column as a monomer, coming off around 155 mL
(Figure 5C). The W75F mutation was created with the intention to affect the hydrophobic core.
Mutating a hydrophilic tryptophan residue with a large hydrophobic phenylalanine seemed to
perturbed the hydrophobic core, which explains the resulting apo-monomeric mitoNEET.2
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A

B

C

Figure 5. A. (Top) Cleaved WT mitoNEET coming off the size exclusion column as a dimer with some
aggregated protein coming off at around 100 mL. B. (Middle) H87C mitoNEET coming off the size
exclusion protein to display the consistency of the purification process. C. The bottom is the H87C W75F
cleaved double mutant. This sample provided little dimer (small peak at 115 mL) and mostly all
monomer (large peak at 150 mL).
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The chromatogram from the first IMAC run of the H87C mutant (not shown) displayed a
step gradient elution. The mitoNEET protein has a 6-histidine tag on it, which coordinates with
the Ni resin inside of the His-Trap column. The histidine tag will create a complex with the Ni
until replaced by the imidazole, which essentially trades places with the tag. This gradient was
intended to find the lowest concentration of imidazole to elute the protein without disturbing the
Fe-S cluster, however it took up to 600 mM to successfully elute. This issue was not observed
with any of the mutants made in the wild type background. The H87C mutants were presenting
lower yields off of the Ni column in addition to the columns being stripped of their Ni. Ni and
protein disappearing together in the presence of imidazole, suggested a chelate formation within
the column. New preparations of the H87C G66A, H87C C83H, and H87C were split and
exposed to two different imidazole buffer conditions. The H87C W75F mutant was exempt from
this due to its apo-configuration. Product concentration was significantly greater when 600 mM
elution buffer was utilized for all three mutants (Figure 6). The same products were tested for
their cluster content with much less difference between groups. The difference in elution patterns
between the H87C mutants and the WT, in addition to the differences in yield, suggests that there
is a natural affinity for nickel in the H87C mutants. This implies the formation of a chelate
complex forming within the HisTrap.
It was suggested that higher imidazole concentrations would affect the protein’s ability to
retain its cluster. Imidazole, which is expected to be a poor ligand for the [Fe-S], at high
concentrations may replace the H87 residue due to the structural similarities between the two
compounds. This would ultimately displace the [Fe-S], making it hard for the protein to retain its
cluster leading to overall loss of the cluster. The mechanism for how mitoNEET and imidazole
interact is still unknown, however Figure 7 supports the hypothesis stated above. The results
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were not drastic enough to stray
tray away from the increased yields the 600 mM imidazole
produced; therefore the imidazole remained elevated for H87C mutants.

Elution Yield - Imidazole

Mutation

H87C G66A

H87C C83H

600 mM Imidizole Elution
400 mM Imidizole Elution

H87C

0

0.5

1
1.5
Concentration (mM)

2

Figure 6. Three mitoNEET mutants’ concentrations were tested after being exposed to two different
elution buffers after IMAC, buffer
uffer 1 (50 mM Tris
Tris-HCL,
HCL, 300 mM NaCl, 400 mM imidizole) and buffer 2
(50 mM Tris- HCL, 300 mM NaCl, 600 mM imidizole).

Cluster Stability - Imidazole

Mutation

H87C G66A

H87C C83H

600 mM Imidizole Elution
400 mM Imidizole Elution

H87C
0

0.1

0.2
0.3
0.4
Absorbance (457 nm)

0.5

0.6

Figure 7.. Three mitoNEET mutants were tested for their cluster stability after being exposed to two
different buffers, buffer 1 (50 mM Tris
Tris-HCL,
HCL, 300 mM NaCl, 400 mM imidizole) and buffer 2 (50 mM
Tris- HCL, 300 mM NaCl, 600 mM imidizole).
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The gel electrophoresis (Figure 88)) accurately displayed the purification process. The bands
display that the procedures were working effectively to select for the dimerr mitoNEET (22 kDa)
protein in the final stages.

Figure 8.. Displays the purification process through samples at each point of the procedure. (1) IMAC 1
flow through (2) IMAC 2 flow through (3) IMAC 1 product (4) IMAC 2 product ((5)
5) Ladder (6) Dialized
product (7) Concentrated Product (8) SEC Product (9) Final concentrated product.

In order to test pH dependent cluster stability, a control was conducted to establish a starting
absorbance value for both samples. Two mitoNEET samples, WT and H87C G66A, were
incubated in deionized water and absorbance at 457 nm was monitored over time (Figure
Figure 9). A
control was helpful to determine the amount of protein necessary to obtain results. Figure 9
displays that a minor initial loss of the cluster will occur in both WT and H87C G66A once
removed from the shaded stock box. This could have been exposure to light and/or a natural loss
of the cluster under sub-optimal
optimal buffer conditions25. The H87C G66A was chosen because of its
almost-identical
al behavior and composition to the H87C single mutant. The single mutant H87C
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mitoNEET was unavailable, therefore the H87C G66A was the best option to observe the
variability in cluster stability between WT and H87C Rieske Fe-S cluster.

MitoNEET WT & H87C G66A Control
0.0600
0.0500
A 457

0.0400
25 uM WT, H2O
0.0300

50 uM WT, H2O

0.0200

25 uM Mut, H2O

0.0100

50 uM Mut, H2O

0.0000
0

50

100

150
Time (min)

200

250

300

Figure 9. The control to see at which concentration, 25 uM or 50 uM, an accurate 457 nm absorbance
rating.

Wild
ild type, after being treated with 100 mM citric acid buffers at pH values of 4, 5, and 6,
6
displayed a continual loss of Fe-S
S cluster over time at all pH
pHs.
s. The loss was much more gradual
in pH 6 compared to pH 4 and 5 (Figure
Figure 10).. MitoNEET is a pH sensitive protein that thrives at
a pH of about 8-8.5.
8.5. Anywhere outside of the pH range 7.5
7.5-9.0 dismantles the ability of
mitoNEET to retain its Fe-S
S cluster. Th
The sample in pH 4 displayed the quickest rate of loss,
followed by the sample at pH 5. This rate is predictable at pH 6 based on the graph with a linear
trend line ( R2 = 0.94469). The direct relationship between pH and cluster loss was expected;
expected the
more extreme
xtreme the pH change, the faster the rate of loss.
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Wild Type MitoNEET pH Stability
0.0250
0.0200

y = -4E-05x + 0.0184
R² = 0.9447

A 457

0.0150

25 uM WT, 100
mM CA pH 4
25 uM WT, 100
mM CA pH 5

0.0100
0.0050

25 uM WT, 100
mM CA pH 6

0.0000
0
-0.0050

50

100

150

200

250

300

Time (min)

Figure 10.. Wild type mitoNEET treated with 100 mM citric acid buffer was monitored continuously
over time to determine the rate of [Fe--S]
S] cluster loss. There were 3 individual samples monitored, one
at pH 4, pH 5, and pH 6.

Wild type mitoNEET was monitored again at pH 5 (Figure 11). Concentration
oncentration of citric acid
and protein were varied in this experiment. There was little difference in the rate of cluster loss
between mitoNEET concentrations. Citric acid buffers at 50 mM had a small effect on cluster
stability, which is apparent in the 25 M sample. This is likely because of low protein-acid
protein
interactions because of the lower concentration. Citric acid buffers at 75 mM and 100 mM
worked similarly to remove the cluster. Negative absorbance values were observed towards the
end This could be due to a dirtyy cuvette, unreliable blan
blank,, or contamination of the sample and/or
blank.
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Wild Type MitoNEET Cluster Stability - pH 5
0.0160
0.0140

A 457

0.0120
0.0100

25 uM WT, 50 mM CA

0.0080

25 uM WT, 75 mM CA

0.0060

25 uM WT, 100 mM CA

0.0040

50 uM WT, 50 mM CA

0.0020

50 uM WT, 75 mM CA

0.0000
-0.0020 0
-0.0040

50 uM WT, 100 mM CA
50

100

150

200

250

300

Time (min)

Figure 11.. Two concentrations of wild typoe mitoNEET were employed, 25 uM and 50 uM. The pH was
kept constant, with the concentration of citric acid ranging from 50 mM to 100 mM. The samples
457nm absorbance was monitored over time.

H87C G66A mitoNEET mutant was exposed to the same conditions. There was a significant
difference in rate of cluster loss between the 50
concentration of 50

and 25

samples (Figure 12).
). At a

mitoNEET displayed a high rate of loss, however this could be because

this sample had more to lose. There was no significant difference between the varying
concentrations of citric acid. As one would suspect, the higher the cconcentration,
oncentration, the quicker the
cluster loss, but the rate is not significantly different.
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H87C G66A mitoNEET Cluster Stability - pH 5
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Figure 12.. The mitoNEET double mutant H87C G66A was treated with a citric acid buffer at 50 mM, 75
mM, and 100 mM. All of the buffers remained constant at a pH of 5
5.. Each of the buffers was applied to
two concentrations of mitoNEET, 25 uM and 50 uM.

H87C G66A mutant was monitored visually as it was treated with each pH buffer. This
experiment corresponds to Figure 13
13. There was a steady decrease in color until a clear solution
resulted. This data visually re-affirms
affirms the conclusion that the farther away from optimal pH, the
higher the rate of loss. One can see color is gone in < 60 minutes at pH 4, >120 minutes at pH 5,
and stays >180 minutes at pH 6.
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Figure 13.. MitoNEET H87C G66A was treated with 100 mM citric acid buffer at three different pHs, 4,
5, and 6. The color of the cluster was monitored visually every 30 minutes.

The crystallography trails were inconclusive because the protein denatured and caame out of
solution prior to running crystal trials.

Conclusion
Based on the experiments used to determine the effects of pH
pH,, it was confirmed that the
H87C mutation significantly increases the stability of the [2Fe
[2Fe-2S] cluster. In addition, the
double mutation, H87C C83H, increases [2Fe
[2Fe-2S]
2S] retention due to the relocation of the histidine.
This relocation exposes the residue to the outermost portion of the cradle where it can interact
with the solvent. However the single C83H mut
mutation
ation somehow decreases cluster retention. The
comparison between all of the mutations and H87C W75F suggests that this mutation perturbs
the hydrophobic core and facilitates [2Fe
[2Fe-2S] loss even in the presence off the stabilizing H87C
mutation. It was also concluded that the H87C mutants have a natural nickel affinity, possibly
forming a chelate.
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Obtaining the crystal structure of each mutation would be helpful in observing their structural
effects. Further crystallization trials will be conducted to determine the stability mechanisms of
the H87C C83H and disruption of the hydrophobic core in the H87C W75F mutation.
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Appendix 1 – Safety Procedures
General Safety Protocols
• Appropriate personal protective equipment (PPE) was worn at all times while working in the
lab to avoid contamination and skin exposure to chemicals.
Biohazard Material
• When handling bacteria and cells, all equipment was disposed of in biohazard waste
containers or cleaned with bleach directly after use.
Chemicals
• All material and safety data sheets (MSDS) were consulted prior to handling any reagents
within the lab. When handling chemicals, gloves were worn at all times to avoid any contact.
• Chemicals deemed dangerous such as unpolymerized acrylamide were handled with care
under direct supervision.
Instruments
• All instruments were operated after adequate training on each machine. All instrumentation
was used under supervision.
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Appendix 2 – Crystallographic Conditions
Plate #
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34

Conditions
100mM Tris pH 8.0, 30% PEG 4000, 50 mM Sodium Chloride
100mM Tris pH 8.0, 30% PEG 4000, 50mM Sodium Chloride
100mM Tris pH 8.0, 30% PEG 4000, 100 mM Sodium Chloride
100mM Tris pH 8.0, 30% PEG 4000, 100 mM Sodium Chloride
100mM Tris pH 8.0, 30% PEG 4000, 200 mM Sodium Chloride
100mM Tris pH 8.0, 30% PEG 4000, 200 mM Sodium Chloride
100mM Tris pH 8.0, 30% PEG 4000, 300 mM Sodium Chloride
100mM Tris pH 8.0, 30% PEG 4000, 300 mM Sodium Chloride
100mM Tris pH 8.0, 30% PEG 4000, 50 mM Lithium Chloride
100mM Tris pH 8.0, 30% PEG 4000, 50 mM Lithium Chloride
100mM Tris pH 8.0, 30% PEG 4000, 100 mM Lithium Chloride
100mM Tris pH 8.0, 30% PEG 4000, 100 mM Lithium Chloride
100mM Tris pH 8.0, 30% PEG 4000, 200 mM Lithium Chloride
100mM Tris pH 8.0, 30% PEG 4000, 200 mM Lithium Chloride
100mM Tris pH 8.0, 30% PEG 4000, 300 mM Lithium Chloride
100mM Tris pH 8.0, 30% PEG 4000, 300mM Lithium Chloride
100mM Tris pH 8.0, 30% PEG 4000, 50mM Lithium Sulfate
100mM Tris pH 8.0, 30% PEG 4000, 50mM Lithium Sulfate
100mM Tris pH 8.0, 30% PEG 4000, 100mM Lithium Sulfate
100mM Tris pH 8.0, 30% PEG 4000, 100mM Lithium Sulfate
100mM Tris pH 8.0, 30% PEG 4000, 200mM Lithium Sulfate
100mM Tris pH 8.0, 30% PEG 4000, 200mM Lithium Sulfate
100mM Tris pH 8.0, 30% PEG 4000, 300mM Lithium Sulfate
100mM Tris pH 8.0, 30% PEG 4000, 300mM Lithium Sulfate
100mM Tris pH 8.0, 30% PEG 4000, 50mM SodiumAcetate
100mM Tris pH 8.0, 30% PEG 4000, 50mM Sodium Acetate
100mM Tris pH 8.0, 30% PEG 4000, 100mM Sodium Acetate
100mM Tris pH 8.0, 30% PEG 4000, 100mM Sodium Acetate
100mM Tris pH 8.0, 30% PEG 4000, 200mM Sodium Acetate
100mM Tris pH 8.0, 30% PEG 4000, 200mM Sodium Acetate
100mM Tris pH 8.0, 30% PEG 4000, 300mM Sodium Acetate
100mM Tris pH 8.0, 30% PEG 4000, 300mM Sodium Acetate
100mM Tris pH 8.0, 30% PEG 4000, 50mM Magnesium Chloride
100mM Tris pH 8.0, 30% PEG 4000, 50mM Magnesium Chloride

35 100mM Tris pH 8.0, 30% PEG 4000, 100mM Magnesium Chloride
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36 100mM Tris pH 8.0, 30% PEG 4000, 100mM Magnesium Chloride
37
38
39
40
41
42
43
44
45
46
47
48

100mM Tris pH 8.0, 30% PEG 4000, 200mM Magnesium Chloride
100mM Tris pH 8.0, 30% PEG 4000, 200mM Magnesium Chloride
100mM Tris pH 8.0, 30% PEG 4000, 300mM Magnesium Chloride
100mM Tris pH 8.0, 30% PEG 4000, 300mM Magnesium Chloride
100mM Tris pH 8.0, 30% PEG 4000, 50 mM Ammonium Sulfate
100mM Tris pH 8.0, 30% PEG 4000, 50 mM Ammonium Sulfate
100mM Tris pH 8.0, 30% PEG 4000, 100 mM Ammonium Sulfate
100mM Tris pH 8.0, 30% PEG 4000, 100 mM Ammonium Sulfate
100mM Tris pH 8.0, 30% PEG 4000, 200 mM Ammonium Sulfate
100mM Tris pH 8.0, 30% PEG 4000, 200 mM Ammonium Sulfate
100mM Tris pH 8.0, 30% PEG 4000, 300 mM Ammonium Sulfate
100mM Tris pH 8.0, 30% PEG 4000, 300 mM Ammonium Sulfate
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